Next‐Generation Approaches for Biomedical Materials Evaluation: Microfluidics and Organ‐on‐a‐Chip Technologies
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202402611 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yuxuan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, Southeast University, Nanjing, Jiangsu, 211189, China. Hauptthemen laut MEDLINE: Lab-On-A-Chip Devices. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 134 Literaturangaben. Gefördert von: Science and Technology Project of Jiangsu Province, Natural Science Foundation of Jiangsu Province, Jiangsu Provincial Key Laboratory for Advanced Metallic Materials.
Abstract (Originalsprache)
Biological evaluation of biomedical materials faces constraints imposed by the limitations of traditional in vitro and animal experiments. Currently, miniaturized and biomimetic microfluidic technologies and organ‐on‐chip systems have garnered widespread attention in the field of drug development. However, their exploration in the context of biomedical material evaluation and medical device development remains relatively limited. In this review, a summary of existing biological evaluation methods, highlighting their respective advantages and drawbacks is provided. The application of microfluidic technologies in the evaluation of biomedical materials, emphasizing the potential of organ‐on‐chip systems as highly biomimetic in vitro models in material evaluation is then focused. Finally, the challenges and opportunities associated with utilizing organ‐on‐chip systems to evaluate biomedical materials in the field of material evaluation are discussed. In conclusion, the integration of advanced microfluidic technologies and organ‐on‐chip systems presents a potential paradigm shift in the biological assessment of biomedical materials, offering the prospective of more accurate and predictive in vitro models in the development of medical devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, Southeast University, Nanjing, Jiangsu, 211189, China.
- Institute of Biomedical Devices (Suzhou), Southeast University, Suzhou, Jiangsu, 215163, China.
- Jiangsu Key Laboratory for Advanced Metallic Materials, Jiangning, Nanjing, Jiangsu, 211189, China.
- State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.
ORCID-Profile: Yuxuan Li, Zhongze Gu, Jing Bai
Förderung
- Science and Technology Project of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- Jiangsu Provincial Key Laboratory for Advanced Metallic Materials
- Science and Technology Program of Suzhou
Zitieren
APA
Li, Y., Sun, K., Shao, Y., Wang, C., Xue, F., Chu, C., Gu, Z., Chen, Z., & Bai, J. (2025). Next‐Generation Approaches for Biomedical Materials Evaluation: Microfluidics and Organ‐on‐a‐Chip Technologies. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402611
Vancouver
Li Y, Sun K, Shao Y, Wang C, Xue F, Chu C, et al. Next‐Generation Approaches for Biomedical Materials Evaluation: Microfluidics and Organ‐on‐a‐Chip Technologies. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402611
BibTeX
@article{Li2025,
author = {Li, Yuxuan and Sun, Ke and Shao, Yi and Wang, Cheng and Xue, Feng and Chu, Chenglin and Gu, Zhongze and Chen, Zaozao and Bai, Jing},
title = {Next‐Generation Approaches for Biomedical Materials Evaluation: Microfluidics and Organ‐on‐a‐Chip Technologies},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202402611}
}
EUVIMED